Please assess the completion status of the following clinical trial:

Trial Title: Progesterone and Second Trimester Bleeding

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Viable pregnancy~* Gestational age between 13 to 26 weeks~* Vaginal bleeding from uterine origin~* Singleton pregnancy~* Normal clotting tests~* Hemodynamically stable woman~Exclusion Criteria:~* Water leak~* Signs of preterm labor~* Fetal malformations incompatible with life~* Uterine malformations and other maternal conditions, i.e. liver disease, breast cancer, active thromboembolic state~* Past preterm birth

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Utrogestan (Type: ACTIVE_COMPARATOR): None
- placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).